News

Gloria Kupferman, AHA’s chief data strategy officer, describes a new benchmarking resource that gives AHA members access to aggregated, de-identified hospital data with standardized metrics on denials, reimbursement and claims processing, to use for analyzing operational and financial efficiency.

Oct. 23 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and other solid forms of prescription drugs.

The Association of University Programs in Health Administration, AHA Institute for Diversity and Health Equity, American College of Healthcare Executives, National Association of Health Services Executives, and National Association of Latino Healthcare Executives announced the Teaching Excellence in Diversity, Equity, Inclusion, Belonging, and Social Justice Award, which will recognize the work and accomplishments of health care academics working toward diversity, equity and inclusion. 

Hospitals and health systems have worked hard to address workforce challenges as the COVID-19 surges continue, but are running out of options and need Congress’ help, writes Robyn Begley, AHA chief nursing officer and CEO of the American Organization for Nursing Leadership, in MedPage Today. 

The AHA released a new COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.

The Food and Drug Administration authorized administering a single booster dose of the Moderna and Johnson & Johnson COVID-19 vaccines to eligible individuals, and authorized eligible recipients of all three authorized COVID-19 vaccines to receive a different COVID-19 vaccine for their initial and booster doses. 

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted unanimously to recommend a single COVID-19 vaccine booster dose at least six months after completing an initial mRNA COVID-19 vaccine series, in the same risk groups for whom CDC recommended a Pfizer booster dose.

Learn how health care leaders such as Matthew Modica, vice president and chief information security officer at BJC HealthCare, are mitigating cyber risks as they take advantage of rapidly advancing technologies and respond to the pandemic.

The Centers for Medicare & Medicaid Services’ Innovation Center released a strategic plan to guide its health care payment and delivery models and priorities over the next decade.

Workplace violence spurred AHA’s Hospitals Against Violence advisory group to create a framework to support hospitals’, health systems’ and security leaders’ efforts to safeguard staff and patients, writes Mary Beth Kingston, R.N., chair of the group, chief nurse officer at Advocate Aurora Health and AHA Board member.

Sens. Roger Marshall, R-Kan., Kyrsten Sinema, D-Ariz., and John Thune, R-S.D., introduced a Senate companion to AHA-supported legislation (H.R. 3173/S. 3018) that would establish requirements for the use of prior authorization under Medicare Advantage plans. 

A mix-and-match vaccine regimen is permissible for international travelers entering the U.S., according to updated Centers for Disease Control and Prevention guidance.

Treatment with subcutaneous interferon beta-1a plus remdesivir was not superior to treatment with remdesivir alone in a clinical trial that enrolled 969 hospitalized adults with COVID-19 pneumonia in the United States, Japan, Mexico, Singapore and South Korea, the National Institutes of Health reported.

The Health Resources and Services Administration Oct. 21 will host the last in a series of webinar sessions on how to apply for a portion of $25.5 billion in COVID-19 relief funds.

Two doses of the Pfizer vaccine are 93% effective at preventing COVID-19 hospitalization among children aged 12 to 18, according to a study at 19 pediatric hospitals released by the Centers for Disease Control and Prevention.

The AHA urged the Centers for Medicare & Medicaid Services to conduct the necessary oversight and enforcement of the No Surprises Act to ensure patients benefit from these new protections and to prevent widespread, negative consequences of any misapplication of the policy.

Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to a National Institutes of Health study released in JAMA Network Open.

The Food and Drug Administration approved the first interchangeable biosimilar product for Humira, a monoclonal antibody used to treat certain inflammatory diseases.

A symposium hosted by the AHA at the HLTH conference featured a panel of experts discussing health transformation in the post-pandemic world.

The Agency for Healthcare Research and Quality seeks input through Nov. 12 on scientific evidence to inform a systematic review of telehealth use during COVID-19.